Working… Menu
Trial record 41 of 382 for:    IFNA2 AND RBV AND genotype

Efficacy Study of New Therapeutic Schedules in Naive Hepatitis C Virus (HCV) Patients Infected With Genotype 3 (HCV-3) (genotype-3)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01121705
Recruitment Status : Completed
First Posted : May 12, 2010
Last Update Posted : August 10, 2011
Information provided by:
Casa Sollievo della Sofferenza IRCCS